Ori Biotech
Ori Biotech develops the IRO platform for cell and gene therapy manufacturing.
$100M Series B+ ·
Led by Chimera Investment · Source: fundraisingfox.com
All 2 rounds ↓Signals
About Ori Biotech
This platform provides flexible tools for scientists to streamline development and automate processes. Ori Biotech aims to enable widespread patient access to cell and gene therapies.
Ori Biotech | 20 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $100M | fundraisingfox.com | ||
| Seed | undisclosed | prnewswire.com |
Timeline
- X account created
- Website created
Founders and team
JB
Jason Bock Co-Founder and CEOsource: oribiotech.comCM
Chris Mason FounderFV
Farlan Veraitch FounderJF
Jason Foster Chief Executive Officer and Executive DirectorTH
Thomas Heathman Vice President of Commercial Operations
Investors
AAmadeus Capital Partners
CChimera Investmentlead investor
DDelin Ventureslead investor
KKindred Capital
NNorthpond Ventures
NNovalis LifeScienceslead investor
OOctopus Ventures
PPuhua Capitallead investor
Companies like Ori Biotech
AAddition Therapeutics$100M Series A · Dec 2025
LLimula$6.8M Seed · Jun 2024
AAspen Neuroscience$115M Series B+ · Nov 2025
CCellular Origins$40M Series A · Jan 2026LLatus Bio$97M Series A · May 2026
TTune Therapeutics$175M Series B+ · Jan 2025
Other companies backed by Chimera Investment
KKitopi$50M Series B+ · Feb 2026
SSynthego$200M Series B+ · Feb 2022
PPlatform ScienceSeries B+ · Apr 2024
CClass TechnologiesSeries B+ · Oct 2023
Chimera Investment portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ori-biotech (get a free API key).